# Quadrise Fuels International continue making progress on all fronts

- Link: https://www.directorstalkinterviews.com/quadrise-fuels-international-continue-making-progress-on-all-fronts/4121035324
- Published: 2021-11-26T07:22:22+00:00
- Author: Giles

**Quadrise Fuels International plc** ([LON:QFI](https://www.directorstalkinterviews.com/company/quadrise-fuels-international-plc/qfi.l))
will provide the following update by way of a presentation of its business development
activities via Investor Meet Company at approximately 12.30pm today, following the
conclusion of the Annual General Meeting of the Company, which commences at 12.00
noon.

Investors who wish to view the presentation can sign up to Investor Meet Company
for free and add Quadrise Fuels International plc at:

https://www.investormeetcompany.com/quadrise-fuels-international-plc/register-investor

Investors who have already registered to meet Quadrise will be invited automatically.

**2021 Overview and Update**

**Business Development**

Despite the continuing global impact of Covid-19 and associated travel restrictions
throughout 2021, Quadrise has continued to engage with our clients to progress key
projects, advance new prospective opportunities and continue the testing and development
of our new low-carbon fuel, bioMSAR™.

Whilst the timetable of some activities has been impacted, the team has worked remotely
with clients to ensure that programmes remain on-track where possible, using our
network of agents and partners who have enabled progress through their in-country
presence. 

Key developments include:

·      **bioMSAR™. **During 2021, bioMSAR™ was successfully tested on 4-stroke engines
at Aquafuel and at the VTT facility in Finland. These tests demonstrated a 26% average
reduction in CO_(2) emissions compared to marine diesel and over 20% lower NOx emissions,
but also, importantly, higher engine efficiency. The next stage of bioMSAR™ testing
will involve commercial 2-stroke and 4-stroke engine testing at OEM testing facilities,
as well as testing on combustion applications. Discussions with crude glycerine 
suppliers are ongoing, and Quadrise are conducting joint research on the production
of glycerine from algae with the University of Greenwich and Algae UK.

·      **MSC.** Quadrise continues to work with MSC Shipmanagement to finalise the
preparatory work to enable the LONO (‘Letter Of No Objection’) fuel trials on board
their commercial container vessels. Our joint focus is now on scheduling bioMSAR
™ testing on MSC’s modern 2-stroke engines with the OEMs, whose resources are currently
limited due to competing future fuel test demands. Alongside this, Quadrise have
been progressing plans for the necessary vessel modifications to enable the commercial-
scale 4,000-hour LONO trials expected to commence in H2 2022.

·      **Morocco.**  During November 2021, the equipment for the MSAR^(®) combustion
trial at the client site (‘Site B’) was shipped to a third-party site in Morocco,
and preparations to commence production of 60mt of MSAR^(®) fuel were completed.
Quadrise is now awaiting client approval to proceed with fuel production and the
Site B trial, which is expected imminently but has been temporarily delayed due 
to an internal management reorganisation at the client. Quadrise also expects to
finalise a further extension to the Material Transfer and Cooperation Agreement,
following the mutual 12 month extension of the original agreement on 28 November
2020. Timely client approval will allow the Site B trial to take place early in 
Q1 2022. The trial results and the final feasibility study for MSAR^(®) use at a
second client site (‘Site A’) are expected to be delivered to the client in Q1 2022.
A subsequent commercial trial can then take place at Site A using the trial equipment
from Site B. Assuming the successful conclusion of these trials, the intention is
to conclude a commercial supply agreement covering one or more of the client’s sites
in Morocco in Q2 2022.

·      **Utah.** Samples from the Greenfield Energy LLC (“Greenfield”) Petroteq 
Oil Sands Plant (‘POSP’) site in Utah were successfully converted into MSAR^(®) 
and bioMSAR™ in September 2021. As a result of these positive results, Quadrise 
and Greenfield agreed that an on-site MSAR^(®) trial would no longer be required,
and instead the parties would jointly work together to secure customers for MSAR
^(®) and bioMSAR™, with a view to initial commercial supply in 2022. Greenfield 
have recently secured funding from Valkor Oil & Gas LLC to acquire 10% (with an 
option for the remaining 90%) of ‘Tar Sands Holdings II’ which offers additional
opportunities for the deployment of Quadrise’s technology to produce MSAR^(®) and
bioMSAR™ for a number of applications. Quadrise is also engaging in discussions 
regarding MSAR^(®) and bioMSAR™ production at other upstream facilities in Utah 
and elsewhere in the USA.

·      **Americas. **In Panama, discussions with regard to MSAR^(®) trials with 
a power plant operator are being progressed via our local agents. Discussions are
also progressing in Mexico regarding MSAR^(®) use at national oil company refineries
and at power plants, via our agents Redliner, with a draft study prepared which 
outlines the economic benefits of MSAR^(®) use across three national oil Company
refineries. Quadrise also continue to progress other opportunities in Central America
and in Ecuador.     

·      **Other. **A meeting is to be held with the Ministry of Energy in KSA to 
promote joint sustainable energy solutions. At this time there are no material updates
with regard to the opportunities in Kuwait, or with JGC, Merlin Energy Resources,
Bitumina, API Poly GCL – though work is continuing as appropriate.

No additional new material information will be disclosed at the presentation and
a copy of the presentation will be available on the QFI website immediately prior
to the webinar commencing.

> **Commenting on the update, Jason Miles, Quadrise Fuels** **Chief Executive Officer,
> said:**
> “We are very pleased to be able to provide a comprehensive update to our shareholders.
> This has been a challenging period for many businesses throughout the world, so
> we are pleased that we have been able to continue making progress on all fronts
> following our successful fundraise earlier in the year.  bioMSAR™ continues to
> exceed expectations in diesel engine testing, and our RDI team are fully engaged
> in delivering our net-zero energy solutions in advance of 2030.  Both MSAR^(®)
> and bioMSAR™ offer compelling solutions today to support the transition to a low
> carbon-economy in the short term.  Our focus for 2022 is to transition our projects
> in various sectors from trials to commercial revenue generators.”

Share on:
